| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 35, 871-882, Copyright © 1994 by Lipid Research, Inc.
EJ Schaefer, S Lamon-Fava, JM Ordovas, SD Cohn, MM Schaefer, WP Castelli and PW Wilson
A decreased high density lipoprotein (HDL) cholesterol level (< 35
mg/dl) has been shown to be a significant independent risk factor for
coronary heart disease (CHD). Moreover, increased HDL cholesterol levels
(> or = 60 mg/dl) are associated with a decreased CHD risk. Levels of
HDL cholesterol and apoA-I, the major protein constituent of HDL, were
measured in plasma from fasting participants in the Framingham Offspring
Study (1,584 men and 1,639 women, mean age 49 +/- 10 years). In this
population, an HDL cholesterol value < 35 mg/dl was observed in 18.2% of
men and 3.8% of women, and these subjects had mean apoA-I levels of 104 and
106 mg/dl, respectively, and triglyceride levels of 234 and 261 mg/dl,
respectively. CHD was observed in 14.2% of men and 14.5% of women in this
category. An HDL cholesterol level > or = 60 mg/dl was observed in 11.7%
of men and 39.3% of women, and these subjects had mean apoA-I levels of 182
and 185 mg/dl, respectively, and mean triglyceride levels of 81 and 75
mg/dl, respectively. CHD was noted in 2.7% of men and 1.9% of women in this
category. HDL cholesterol levels were much more strongly related to
triglycerides (r = -0.54 in men and -0.47 in women) than was apoA-I (r =
-0.26 in men and -0.13 in women). The relationship between plasma HDL
cholesterol and triglyceride levels was not linear. In both men and women,
triglycerides, body mass index (BMI), and alcohol intake contributed
significantly to HDL cholesterol and apoA-I variability.
ARTICLES
Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study
Lipid Metabolism Laboratory, Tufts University, Boston, MA 02111.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Ferns and V. Keti HDL-cholesterol modulation and its impact on the management of cardiovascular risk Ann Clin Biochem, March 1, 2008; 45(2): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O. Mudd, B. A. Borlaug, P. V. Johnston, B. G. Kral, R. Rouf, R. S. Blumenthal, and P. O. Kwiterovich Jr Beyond Low-Density Lipoprotein Cholesterol: Defining the Role of Low-Density Lipoprotein Heterogeneity in Coronary Artery Disease J. Am. Coll. Cardiol., October 30, 2007; 50(18): 1735 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J Fogli-Cawley, J. T Dwyer, E. Saltzman, M. L McCullough, L. M Troy, J. B Meigs, and P. F Jacques The 2005 Dietary Guidelines for Americans and risk of the metabolic syndrome Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1193 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bruckert, R. Pamphile, F. McCoy, and P. Andre Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F23 - F26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chapman Beyond LDL-cholesterol reduction: the way ahead in managing dyslipidaemia Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F56 - F62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Maki, M. E. Van Elswyk, D. McCarthy, S. P. Hess, P. E. Veith, M. Bell, P. Subbaiah, and M. H. Davidson Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol J. Am. Coll. Nutr., June 1, 2005; 24(3): 189 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Barter Role of nicotinic acid in raising high-density lipoprotein cholesterol (HDL-C) to reduce cardiovascular risk: an Asian/Pacific consensus: The Pan-Asian Consensus Panel On Hdl-C The British Journal of Diabetes & Vascular Disease, March 1, 2005; 5(2_suppl): S1 - S15. [Abstract] [PDF]
|
|
|
|
 |
|
 P. G. Yancey, B. F. Asztalos, N. Stettler, D. Piccoli, D. L. Williams, M. A. Connelly, and G. H. Rothblat SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome J. Lipid Res., September 1, 2004; 45(9): 1724 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, S. Lamon-Fava, J. Otvos, A. H. Lichtenstein, W. Velez-Carrasco, J. R. McNamara, J. M. Ordovas, and E. J. Schaefer Fish Consumption Shifts Lipoprotein Subfractions to a Less Atherogenic Pattern in Humans J. Nutr., July 1, 2004; 134(7): 1724 - 1728. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Assmann and A. M. Gotto Jr HDL Cholesterol and Protective Factors in Atherosclerosis Circulation, June 15, 2004; 109(23_suppl_1): III-8 - III-14. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. E. Brousseau, E. J. Schaefer, M. L. Wolfe, L. T. Bloedon, A. G. Digenio, R. W. Clark, J. P. Mancuso, and D. J. Rader Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol N. Engl. J. Med., April 8, 2004; 350(15): 1505 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Yancey, M.-a. Kawashiri, R. Moore, J. M. Glick, D. L. Williams, M. A. Connelly, D. J. Rader, and G. H. Rothblat In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux J. Lipid Res., February 1, 2004; 45(2): 337 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, J. D. Otvos, S. Lamon-Fava, W. V. Carrasco, A. H. Lichtenstein, J. R. McNamara, J. M. Ordovas, and E. J. Schaefer Men and Women Differ in Lipoprotein Response to Dietary Saturated Fat and Cholesterol Restriction J. Nutr., November 1, 2003; 133(11): 3428 - 3433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Witting, J. N. Maiorano, and W. S. Davidson Ceramide Enhances Cholesterol Efflux to Apolipoprotein A-I by Increasing the Cell Surface Presence of ATP-binding Cassette Transporter A1 J. Biol. Chem., October 10, 2003; 278(41): 40121 - 40127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Yancey, A. E. Bortnick, G. Kellner-Weibel, M. de la Llera-Moya, M. C. Phillips, and G. H. Rothblat Importance of Different Pathways of Cellular Cholesterol Efflux Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zuchner, A. D. Sperfeld, J. Senderek, B. Sellhaus, C. O. Hanemann, and J. M. Schroder A novel nonsense mutation in the ABC1 gene causes a severe syringomyelia-like phenotype of Tangier disease Brain, April 1, 2003; 126(4): 920 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]
|
|
|
|
 |
|
 M. GLICK Screening for traditional risk factors for cardiovascular disease: A review for oral health care providers J Am Dent Assoc, March 1, 2002; 133(3): 291 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J Schaefer Lipoproteins, nutrition, and heart disease Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Chisholm, E. R. Burleson, G. S. Shelness, and J. S. Parks ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL J. Lipid Res., January 1, 2002; 43(1): 36 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sampietro, F. Bigazzi, B. Dal Pino, S. Fusaro, F. Greco, M. Tuoni, and A. Bionda Increased Plasma C-Reactive Protein in Familial Hypoalphalipoproteinemia: A Proinflammatory Condition? Circulation, January 1, 2002; 105(1): 11 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Panagotopulos, E. M. Horace, J. N. Maiorano, and W. S. Davidson Apolipoprotein A-I Adopts a Belt-like Orientation in Reconstituted High Density Lipoproteins J. Biol. Chem., November 9, 2001; 276(46): 42965 - 42970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. De Oliveira e Silva, D. Foster, M. McGee Harper, C. E. Seidman, J. D. Smith, J. L. Breslow, and E. A. Brinton Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II Circulation, November 7, 2000; 102(19): 2347 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Mahley, J. Pépin, K. E. Palaoglu, M. J. Malloy, J. P. Kane, and T. P. Bersot Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype J. Lipid Res., August 1, 2000; 41(8): 1290 - 1301. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Brousseau, G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size J. Lipid Res., July 1, 2000; 41(7): 1125 - 1135. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Brousseau, E. J. Schaefer, J. Dupuis, B. Eustace, P. Van Eerdewegh, A. L. Goldkamp, L. M. Thurston, M. G. FitzGerald, D. Yasek-McKenna, G. O'Neill, et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds J. Lipid Res., March 1, 2000; 41(3): 433 - 441. [Abstract] [Full Text]
|
|
|
|
|
|
W. Velez-Carrasco, A. H. Lichtenstein, Z. Li, G. G. Dolnikowski, S. Lamon-Fava, F. K. Welty, and E. J. Schaefer Apolipoprotein A-I and A-II Kinetic Parameters as Assessed by Endogenous Labeling With [2H3]Leucine in Middle-Aged and Elderly Men and Women Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nanchahal, W D. Ashton, and D. A Wood Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women Int. J. Epidemiol., February 1, 2000; 29(1): 57 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lamon-Fava, J. M. Ordovas, and E. J. Schaefer Estrogen Increases Apolipoprotein (Apo) A-I Secretion in Hep G2 Cells by Modulating Transcription of the Apo A-I Gene Promoter Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2960 - 2965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Bersot, G. L. Vega, S. M. Grundy, K. E. Palaoglu, P. Atagündüz, S. Özbayrakçi, O. Gökdemir, and R. W. Mahley Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population J. Lipid Res., March 1, 1999; 40(3): 432 - 438. [Abstract] [Full Text]
|
|
|
|
|
|
F. K. Welty, C. Lahoz, K. L. Tucker, J. M. Ordovas, P. W. F. Wilson, and E. J. Schaefer Frequency of ApoB and ApoE Gene Mutations as Causes of Hypobetalipoproteinemia in the Framingham Offspring Population Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1745 - 1751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF]
|
|
|
|
|
|
M. Tilly-Kiesi, A. H. Lichtenstein, J. Joven, E. Vilella, M. C. Cheung, W. V. Carrasco, J. M. Ordovas, G. Dolnikowski, and E. J. Schaefer Impact of Gender on the Metabolism of Apolipoprotein A-I in HDL Subclasses LpAI and LpAI:AII in Older Subjects Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3513 - 3518. [Abstract] [Full Text]
|
|
|
|
|
|
M. Tilly-Kiesi, A. H. Lichtenstein, J. M. Ordovas, G. Dolnikowski, R. Malmstrom, M.-R. Taskinen, and E. J. Schaefer Subjects With ApoA-I(Lys107->0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 873 - 880. [Abstract] [Full Text]
|
|
|
|
|
|
S. Lamon-Fava, P. W.F. Wilson, and E. J. Schaefer Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women: The Framingham Offspring Study Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1509 - 1515. [Abstract] [Full Text]
|
|
|
|
|
|
B. D. Mitchell, C. M. Kammerer, J. Blangero, M. C. Mahaney, D. L. Rainwater, B. Dyke, J. E. Hixson, R. D. Henkel, R. M. Sharp, A. G. Comuzzie, et al. Genetic and Environmental Contributions to Cardiovascular Risk Factors in Mexican Americans: The San Antonio Family Heart Study Circulation, November 1, 1996; 94(9): 2159 - 2170. [Abstract] [Full Text]
|
|
|
|
|
|
E. J. Schaefer, A. H. Lichtenstein, S. Lamon-Fava, J. H. Contois, Z. Li, H. Rasmussen, J. R. McNamara, and J. M. Ordovas Efficacy of a National Cholesterol Education Program Step 2 Diet in Normolipidemic and Hypercholesterolemic Middle-Aged and Elderly Men and Women Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1079 - 1085. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
